Please assess the completion status of the following clinical trial:

Trial Title: The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Post-menopausal stage I-III breast cancer patients~* Starting or about to start aromatase inhibitor~* English speaking with ability to read, write and use a computer to watch and listen to an educational module.~* Able to give informed consent~Exclusion Criteria:~* Aromatase inhibitor (AI) use for more than 6 months~* Metastatic breast cancer~* Non-English speaking, or unable to read, write or use a computer to watch and listen to an educational module.~* Unable to give informed consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Education and exercise intervention (Type: ACTIVE_COMPARATOR): The intervention module will contain a brief series of slides with a voice-over. An occupational therapist will review recommended exercises.
- Education and general exercise (Type: PLACEBO_COMPARATOR): The control module will contain a brief series of slides with a voice-over. A physical therapist with experience in treating breast cancer patients will demonstrate a series of 4-5 general stretching and toning exercises.

Based on this trial design, predict the completion outcome and termination type (if applicable).